Advanced Medical Solutions Group plc (AIM:AMS) acquired Sealantis Ltd. for approximately £19 million on January 31, 2019. As per the terms, the consideration is paid in cash, to be funded from existing cash resources, in addition, Advanced Medical Solutions Group plc will pay royalties, in-line with market rates, on future sales of existing products in development until the end of 2027. Daniel Adams, Gary Clarence and Patrick Robb of Investec Bank plc acted as nominated advisor and broker to Advanced Medical Solutions Group plc. Sophie McGrath and Ella Sharpley of Goodwin Procter (Uk) LLP acted as legal advisors to Advanced Medical Solutions Group plc (AIM:AMS). Advanced Medical Solutions Group plc (AIM:AMS) completed the acquisition of Sealantis Ltd. on January 31, 2019.